JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
FUB-AMB aka MMB-FUBINACA and AMB-FUBINACA is a potent agonist of the CB1 and CB2 receptors, is indazole-based and was developed by Pfizer in 2009 but never made it into trials.
